MARAVAI LIFESCIENCES HOLDINGS, INC.
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI): 17 pipeline candidates · ~17 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
17.4 months
D/E 1.63
Lead: Approved
17 candidates
N/A
N/A
A transparent, data-derived signal for MARAVAI LIFESCIENCES HOLDINGS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.9B
Cash
$165.9M
Quarterly Burn
$33.0M
Runway
17.4 mo
Revenue
$65.8M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (17 candidates)
| Drug | Phase |
|---|---|
| acetazolamide | Approved |
| azithromycin | Approved |
| baclofen | Approved |
| candesartan cilexetil | Approved |
| cleancap-enabled mrna programs | Approved |
| clindamycin | Approved |
| diclofenac | Approved |
| ibrutinib | Approved |
| ibuprofen | Approved |
| lidocaine | Approved |
Showing 10 of 17 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
157
Total value held
$344.8M
| Holder | Shares | Value |
|---|---|---|
| gtcr llc | 20,150,005 | $57.0M |
| vanguard capital management llc | 10,899,404 | $30.8M |
| braidwell lp | 10,240,164 | $29.0M |
| blackrock, inc. | 9,345,268 | $26.4M |
| 12 west capital management lp | 7,260,195 | $20.5M |
| mackenzie financial corp | 6,306,425 | $17.8M |
| first eagle investment management, llc | 5,048,672 | $14.3M |
| renaissance technologies llc | 4,264,689 | $12.1M |
| morgan stanley | 3,319,325 | $9.4M |
| point72 asset management, l.p. | 3,205,496 | $9.1M |
Showing top 10 of 157 institutional holders of MARAVAI LIFESCIENCES HOLDINGS, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in MARAVAI LIFESCIENCES HOLDINGS, INC.'s pipeline?
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) has 17 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is MARAVAI LIFESCIENCES HOLDINGS, INC.'s lead drug candidate?
MARAVAI LIFESCIENCES HOLDINGS, INC.'s most advanced tracked candidate is acetazolamide (Approved).
What is MARAVAI LIFESCIENCES HOLDINGS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, MARAVAI LIFESCIENCES HOLDINGS, INC. has approximately 17.4 months of cash runway.
What is MARAVAI LIFESCIENCES HOLDINGS, INC.'s market capitalization?
MARAVAI LIFESCIENCES HOLDINGS, INC.'s market capitalization is approximately $1.9B.
Who is the CEO of MARAVAI LIFESCIENCES HOLDINGS, INC.?
Mr. Bernd Brust is the chief executive officer of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).
Get the full picture on MARAVAI LIFESCIENCES HOLDINGS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.